Thrive Wealth Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $349K | Sell |
9,077
-63
| -0.7% | -$2.42K | 0.06% | 160 |
|
|
2025
Q1 | $354K | Buy |
9,140
+1,891
| +26% | +$73.3K | 0.07% | 146 |
|
|
2024
Q4 | $245K | Sell |
7,249
-4,487
| -38% | -$152K | 0.04% | 172 |
|
|
2024
Q3 | $480K | Buy |
11,736
+124
| +1% | +$5.07K | 0.09% | 119 |
|
|
2024
Q2 | $447K | Sell |
11,612
-30
| -0.3% | -$1.16K | 0.09% | 117 |
|
|
2024
Q1 | $499K | Buy |
11,642
+2,198
| +23% | +$94.2K | 0.1% | 106 |
|
|
2023
Q4 | $350K | Sell |
9,444
-1,507
| -14% | -$55.8K | 0.08% | 128 |
|
|
2023
Q3 | $397K | Buy |
10,951
+254
| +2% | +$9.21K | 0.11% | 105 |
|
|
2023
Q2 | $381K | Sell |
10,697
-1,312
| -11% | -$46.8K | 0.1% | 114 |
|
|
2023
Q1 | $427K | Buy |
12,009
+1,379
| +13% | +$49.1K | 0.11% | 111 |
|
|
2022
Q4 | $374K | Buy |
10,630
+336
| +3% | +$11.8K | 0.11% | 110 |
|
|
2022
Q3 | $303K | Sell |
10,294
-402
| -4% | -$11.8K | 0.11% | 116 |
|
|
2022
Q2 | $582K | Buy |
10,696
+6,455
| +152% | +$351K | 0.2% | 67 |
|
|
2022
Q1 | $231K | Buy |
+4,241
| New | +$231K | 0.07% | 141 |
|